The effect of IFNβ-1b on the evolution of enhancing lesions in secondary progressive MS
Article 2001 en
Authors
PB
P A Brex
PM
P. D. Molyneux
PS
Pauline Smiddy
Abstract
1 min read
IFNbeta-1b reduced the number of new enhancing lesions, with a greater effect on small lesions. However, when a new enhancing lesion did become established, treatment with IFNbeta-1b did not alter its subsequent course.
P. D. Molyneux, Ludwig Kappos, Chris H. Polman, Carlo Pozzilli, Frederik Barkhof, Massimo Filippi, Tarek Yousry, David W. Hahn, Klaus Wagner, Mahdiyeh Khabbaz Koche Ghazi, K. Beckmann, Frank Dahlke, Nicholas Losseff, Gareth J. Barker, Alan J. Thompson, D. H. Miller
Matilde Inglese, J.H.T.M. van Waesberghe, Marco Rovaris, K. Beckmann, Frederik Barkhof, David W. Hahn, Ludwig Kappos, David H. Miller, C. Polman, Carlo Pozzilli, Alan J. Thompson, Tarek Yousry, Klaus Wagner, Giancarlo Comi, Massimo Filippi
Massimo Filippi, Tarek Yousry, A. Campi, Christoph Kandziora, Bruno Colombo, Raymond Voltz, Vittorio Martinelli, Simone Spuler, S. Bressi, Giuseppe Scotti, Gıancarlo Comı
Discussion(0)
No comments yet. Be the first to comment.